Forge Biologics to Present at Jefferies Gene Therapy / Editing Summit - Forge Biologics

Forge Biologics to Present at Jefferies Gene Therapy / Editing Summit

COLUMBUS, OHIO October 27, 2021 – Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced today that Timothy J. Miller, Ph.D., Forge’s CEO, President, and Co-Founder, will deliver a company presentation at the Jefferies Gene Therapy / Editing Summit on Thursday, October 28, at 12:30 p.m. ET.

The conference will take place October 27-28, 2021 virtually. A live replay of the presentation will be available on the Jefferies conference website for 30 days following the presentation:

The Forge Biologics leadership team, including Dr. Miller; John Maslowski, Chief Commercial Officer; Christina Perry, Vice President of Finance and Investor Relations; and Magdalena Tyrpien, Vice President and Head of Business Development, will be available for 1:1 meetings virtually throughout the conference.  

About Forge Biologics

Forge Biologics is a hybrid gene therapy contract manufacturing and therapeutics development company. Forge’s mission is to enable access to life changing gene therapies and help bring them from idea to reality. Forge has a 175,000 square foot facility in Columbus, Ohio, The Hearth, to serve as its headquarters. The Hearth is a custom-designed cGMP facility dedicated to AAV vector manufacturing and will host end-to-end manufacturing services to accelerate gene therapy programs from preclinical through clinical and commercial stage manufacturing. By taking a patients-first approach, Forge aims to accelerate the timelines of these transformative medicines for those who need them the most.  To learn more, visit

Media Inquiries 

Marina Corleto

Senior Manager, Marketing and Communications   

Families and Clinician Inquiries

Dr. Maria Escolar

Chief Medical Officer

Business Development  

Magdalena Tyrpien  

Vice President, Head of Business Development   

Client Development

John Maslowski

Chief Commercial Officer

Investor Relations  

Christina Perry, MSA, CPA  

Vice President, Finance and Investor Relations   


0/5 (0 Reviews)